Literature DB >> 2012610

Isolation of two N-monosubstituted protoporphyrins, bearing either the whole drug or a methyl group on the pyrrole nitrogen atom, from liver of mice given griseofulvin.

A E Holley1, Y Frater, A H Gibbs, F De Matteis, J H Lamb, P B Farmer, S Naylor.   

Abstract

1. A hepatic green pigment with inhibitory properties towards the enzyme ferrochelatase has been isolated from the liver of mice treated with griseofulvin and identified as N-methylprotoporphyrin. 2. All four structural isomers of N-methylprotoporphyrin have been demonstrated to be present, NA, where ring A of protoporphyrin IX is N-methylated, being the predominant isomer. 3. In addition to N-methylprotoporphyrin, a second green pigment, present in far greater amounts, was also isolated from the liver of griseofulvin-treated mice. This second green pigment is also an N-monosubstituted protoporphyrin, but in this case the substituent on the pyrrole nitrogen atom appears to be intact griseofulvin rather than a methyl group. 4. The fragmentation of this adduct in tandem m.s. studies suggests that griseofulvin is bound to the pyrrole nitrogen through one of its carbon atoms and further suggests that N-methylprotoporphyrin may arise as a secondary product from the major griseofulvin pigment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2012610      PMCID: PMC1149987          DOI: 10.1042/bj2740843

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Effects of griseofulvin on enzymes associated with phase I and II of drug metabolism.

Authors:  M T Williams; L Simonet
Journal:  Biochem Pharmacol       Date:  1986-08-01       Impact factor: 5.858

Review 2.  Cytochrome P-450 catalysis: radical intermediates and dehydrogenation reactions.

Authors:  P R Ortiz de Montellano
Journal:  Trends Pharmacol Sci       Date:  1989-09       Impact factor: 14.819

3.  Behavior of hepatic microsomal cytochromes after treatment of mice with drugs known to disturb porphyrin metabolism in liver.

Authors:  O Wada; Y Yano; G Urata; K Nakao
Journal:  Biochem Pharmacol       Date:  1968-04       Impact factor: 5.858

4.  N-methylporphyrins.

Authors:  A H Jackson; G R Dearden
Journal:  Ann N Y Acad Sci       Date:  1973       Impact factor: 5.691

5.  Absorption, metabolism and excretion of 14C-griseofulvin in man.

Authors:  C C Lin; J Magat; R Chang; J McGlotten; S Symchowicz
Journal:  J Pharmacol Exp Ther       Date:  1973-11       Impact factor: 4.030

Review 6.  Occurrence and biological properties of N-methyl protoporphyrin.

Authors:  F De Matteis; A H Gibbs; A E Holley
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

7.  Oxidative demethylation of 14C-griseofulvin by liver microsomes of rats and mice.

Authors:  R L Chang; S Symchowicz; C C Lin
Journal:  Biochem Pharmacol       Date:  1973-06-01       Impact factor: 5.858

Review 8.  Disruption of hepatic heme biosynthesis after interaction of xenobiotics with cytochrome P-450.

Authors:  G S Marks; S A McCluskey; J E Mackie; D S Riddick; C A James
Journal:  FASEB J       Date:  1988-09       Impact factor: 5.191

9.  Studies on the inhibition of ferrochelatase by N-alkylated dicarboxylic porphyrins. Steric factors involved and evidence that the inhibition is reversible.

Authors:  F De Matteis; A H Gibbs; C Harvey
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

10.  Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells.

Authors:  G S Marks; D T Allen; C T Johnston; E P Sutherland; K Nakatsu; R A Whitney
Journal:  Mol Pharmacol       Date:  1985-04       Impact factor: 4.436

View more
  7 in total

1.  Formation of N-methyl protoporphyrin in chemically-induced protoporphyria. Studies with a novel porphyrogenic agent.

Authors:  Y Frater; A Brady; E A Lock; F De Matteis
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

2.  Labelling in vivo and chirality of griseofulvin-derived N-alkylated protoporphyrins.

Authors:  F De Matteis; A H Gibbs; S R Martin; R L Milek
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

3.  Determination of the structure of an N-substituted protoporphyrin isolated from the livers of griseofulvin-fed mice.

Authors:  R M Bellingham; A H Gibbs; F de Matteis; L Y Lian; G C Roberts
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

4.  N-alkylprotoporphyrin formation and hepatic porphyria in dogs after administration of a new antiepileptic drug candidate: mechanism and species specificity.

Authors:  Jean-Marie Nicolas; Hugues Chanteux; Valérie Mancel; Guy-Marie Dubin; Brigitte Gerin; Ludovicus Staelens; Olympe Depelchin; Sophie Kervyn
Journal:  Toxicol Sci       Date:  2014-06-27       Impact factor: 4.849

5.  A metabolomic perspective of griseofulvin-induced liver injury in mice.

Authors:  Ke Liu; Jiong Yan; Madhav Sachar; Xinju Zhang; Ming Guan; Wen Xie; Xiaochao Ma
Journal:  Biochem Pharmacol       Date:  2015-09-05       Impact factor: 5.858

6.  Griseofulvin impairs intraerythrocytic growth of Plasmodium falciparum through ferrochelatase inhibition but lacks activity in an experimental human infection study.

Authors:  Clare M Smith; Ante Jerkovic; Thy Thuc Truong; Simon J Foote; James S McCarthy; Brendan J McMorran
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

7.  A Novel Mechanism for NF-κB-activation via IκB-aggregation: Implications for Hepatic Mallory-Denk-Body Induced Inflammation.

Authors:  Yi Liu; Michael J Trnka; Shenheng Guan; Doyoung Kwon; Do-Hyung Kim; J-J Chen; Peter A Greer; A L Burlingame; Maria Almira Correia
Journal:  Mol Cell Proteomics       Date:  2020-09-10       Impact factor: 5.911

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.